Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction.
We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.
Dominguez-Rodriguez
Alberto
A
Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain. adrvdg@hotmail.com
Abreu-Gonzalez
Pedro
P
Garcia-Gonzalez
Martín
M
Reiter
Russel J
RJ
D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D002940:Circadian Rhythm; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016015:Logistic Models; D008297:Male; D008550:Melatonin / Q000097:blood*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood*; D011379:Prognosis; D011446:Prospective Studies
D015415:Biomarkers; D002097:C-Reactive Protein; D008550:Melatonin